订阅小程序
旧版功能

AGITG ASCEND: Randomised, Double-Blind Phase II Study of Certepetide or Placebo Added to Gemcitabine Plus Nab-Paclitaxel in Patients with Untreated Metastatic Pancreatic Ductal Adenocarcinoma: Initial Results.

Journal of Clinical Oncology(2025)

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要